Interleukin-6 (IL-6) is still the leading biomarker of the metabolic and aging related disorders

Simple item page
dc.contributor.authorErol A.
dc.date.accessioned2024-07-22T08:22:43Z
dc.date.available2024-07-22T08:22:43Z
dc.date.issued2007
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1016/j.mehy.2007.01.021
dc.identifier.issn03069877
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19206
dc.language.isoEnglish
dc.subjectAging
dc.subjectBiological Markers
dc.subjectCardiovascular System
dc.subjectCytokines
dc.subjectExercise
dc.subjectGene Expression Regulation
dc.subjectHumans
dc.subjectInterleukin-6
dc.subjectMetabolism
dc.subjectModels, Biological
dc.subjectModels, Theoretical
dc.subjectMuscles
dc.subjectbiological marker
dc.subjectfatty acid
dc.subjectglucose
dc.subjectglycogen
dc.subjectinsulin
dc.subjectinterleukin 6
dc.subjectaging
dc.subjectcytokine production
dc.subjectdiabetes mellitus
dc.subjectexercise
dc.subjectglucose homeostasis
dc.subjecthuman
dc.subjectinflammation
dc.subjectinsulin resistance
dc.subjectletter
dc.subjectmetabolic disorder
dc.subjectmetabolic syndrome X
dc.subjectmuscle atrophy
dc.subjectobesity
dc.subjectpriority journal
dc.titleInterleukin-6 (IL-6) is still the leading biomarker of the metabolic and aging related disorders
dc.typeLetter

Files

Collections

Scopus Koleksiyonu